Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa

Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa

Item

http://www.wikidata.org/entity/Q28191349

Q28191349

about

Involvement of members of the cadherin superfamily in cancer Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia.Mechanisms of resistance to decitabine in the myelodysplastic syndrome.Intra- and interindividual epigenetic variation in human germ cells.Clinicopathological significance and potential drug target of T-cadherin in NSCLC.Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA Aberrant DNA Methylation Is Associated with a Poor Outcome in Juvenile Myelomonocytic Leukemia.The silence of the genes: epigenetic disturbances in haematopoietic malignancies.The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt/β-catenin signaling and silenced in common carcinomas.Treatment of PC12 cells with nerve growth factor induces proteasomal degradation of T-cadherin that requires tyrosine phosphorylation of its cadherin domain.Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse.Pretreatment long interspersed element (LINE)-1 methylation levels, not early hypomethylation under treatment, predict hematological response to azacitidine in elderly patients with acute myeloid leukemia DNA methylation: its role in cancer development and therapy.Downregulation of JUNB mRNA expression in advanced phase chronic myelogenous leukemia.Epigenetic reprogramming of host genes in viral and microbial pathogenesis Prognostic significance of CDH13 hypermethylation and mRNA in NSCLC.High expression of ETS2 predicts poor prognosis in acute myeloid leukemia and may guide treatment decisions.Epigenetic regulation in gallbladder cancer: Promoter methylation profiling as emergent novel biomarkers.Synovial fluid proteome in rheumatoid arthritis.Significance of Inactivated Genes in Leukemia: Pathogenesis and Prognosis Correlation between T-cadherin gene expression and aberrant methylation of T-cadherin promoter in human colon carcinoma cells.Mtss1 is a critical epigenetically regulated tumor suppressor in CML.Stromal cells expressing hedgehog-interacting protein regulate the proliferation of myeloid neoplasms.Methylation patterns in CD34 positive chronic myeloid leukemia blast crisis cells.CpG island methylator phenotype and its relationship with prognosis in adult acute leukemia patients.Frequent promoter methylation and gene silencing of CDH13 in pancreatic cancer.Methylation status of CEBPA gene promoter in chronic myeloid leukemia.T-cadherin expression in uterine leiomyoma.Phase I/II study of low-dose azacytidine in patients with chronic myeloid leukemia who have minimal residual disease while receiving therapy with tyrosine kinase inhibitors.

P2860

Q33899441-25A83EB5-01D5-463D-917C-546E61BDD153 Q33961765-CB529FCC-F2B6-4610-8BA6-A458DBA835D1 Q33999539-5811C7F7-092E-4A26-8BAA-09535CCBB4E7 Q34658413-0EFE05BF-8587-4100-A9DC-1E5A531EFB69 Q34783319-81336307-2F7E-4EF0-8223-F5BF0A27AF53 Q35080754-E3098693-1EA5-416B-A5EE-EEA166C57467 Q35882742-9B1F6B46-687A-419C-B551-4C0A56FB5DCA Q36066276-90FF0577-CD43-45C0-A282-E8EE0F038F2D Q36186624-BAAE8D2A-299E-4133-82AB-9CE0E86FE313 Q36459972-7C94E291-4A9F-4937-B78A-45DDA76F3F6B Q36835063-BB6C0742-0F1C-417A-8CA1-8AD94A681607 Q36975817-29B0601C-1EF1-41DB-9D43-F4B818C5354F Q36986433-BBEDD915-945F-44A5-9A0D-9F2A1097A20B Q37324449-6C7AFA16-6CF5-44C6-A15A-7F56739165F4 Q37781197-43FE4683-6843-42A4-801A-EE11EB40C77C Q38266450-72A162D5-1340-4AA9-8132-69BD3F316B3E Q38671635-A0780300-C9C8-489D-B0EB-EF7758FBC7E9 Q38844664-B21E01EA-A2FD-4DE7-8EEA-2D3555B8C39E Q38856510-013617D4-B896-4C1A-974C-B479695A998A Q39350173-C62485AF-9B29-4B88-A38F-24714A8BAEC2 Q39596878-2B476D48-A612-4E1C-BBBE-B025947D5538 Q41085680-D8674D41-90A9-4D59-8210-277EBE8CB0A7 Q42190228-04EB73B5-F4E1-4726-9DD3-A7C2CA3399C6 Q42765023-072C90F8-EAE9-4F69-AB01-21BE16CB6E66 Q43649407-F935ADAF-018E-4824-B003-B0E8BE899353 Q44971693-2DC8EE83-320A-4D7E-B423-AFD419495853 Q54266084-9089F6DE-7FA5-45A2-AB0D-A2743D305ADF Q54269861-2E97012A-87B6-48D1-9CF3-C94D9E0B5C8E Q54839818-D43EBC0F-5C69-4923-89F1-01A04197FD18

P2860

Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa

Item

http://www.wikidata.org/entity/Q28191349

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu